Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
7.11
-0.03 (-0.42%)
At close: Feb 4, 2026
SHE:002370 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 587.81 | 743.85 | 720.47 | 757.62 | 821.11 | 902.94 |
Cash & Short-Term Investments | 617.89 | 743.85 | 720.47 | 757.62 | 821.11 | 902.94 |
Cash Growth | -10.33% | 3.25% | -4.90% | -7.73% | -9.06% | -23.50% |
Accounts Receivable | 132.52 | 111.68 | 111.8 | 115.65 | 85.24 | 160.71 |
Other Receivables | 11.45 | 26.4 | 29.19 | 15.14 | 1.18 | 116.35 |
Receivables | 143.97 | 138.08 | 140.99 | 130.79 | 86.42 | 277.06 |
Inventory | 52.77 | 70.13 | 89.47 | 95.2 | 60.9 | 64.88 |
Other Current Assets | 1.35 | 3.1 | 4.24 | 21.23 | 27.41 | 29.97 |
Total Current Assets | 815.98 | 955.16 | 955.18 | 1,005 | 995.85 | 1,275 |
Property, Plant & Equipment | 301.49 | 338.11 | 364.79 | 385.89 | 433.99 | 487.75 |
Long-Term Investments | 36.69 | 38.49 | 37.75 | 40.96 | 58.27 | 75.14 |
Other Intangible Assets | 43.29 | 54.2 | 59.21 | 57.22 | 51.57 | 49.95 |
Long-Term Deferred Tax Assets | - | - | - | 0.25 | - | - |
Long-Term Deferred Charges | 16.49 | 15.82 | 11.37 | 22.14 | 71.1 | 68.65 |
Other Long-Term Assets | - | - | 1.08 | 12.56 | - | - |
Total Assets | 1,214 | 1,402 | 1,429 | 1,524 | 1,611 | 1,956 |
Accounts Payable | 50.02 | 45.77 | 51.8 | 89.83 | 53.93 | 44.95 |
Accrued Expenses | 7.6 | 17.08 | 16.98 | 22.73 | 21.65 | 25.42 |
Short-Term Debt | - | 30.06 | 50.06 | 50.06 | - | - |
Current Portion of Long-Term Debt | - | 301.7 | - | - | 110.16 | - |
Current Portion of Leases | - | - | - | 1.7 | 1.35 | - |
Current Income Taxes Payable | 1.97 | - | - | - | - | - |
Current Unearned Revenue | 2.14 | 2.23 | 7.96 | 14.47 | 2.77 | 3.61 |
Other Current Liabilities | 17.73 | 19.6 | 35.01 | 43.58 | 24.3 | 217.54 |
Total Current Liabilities | 79.46 | 416.44 | 161.8 | 222.38 | 214.15 | 291.52 |
Long-Term Debt | - | - | 639.48 | 900.01 | 861.58 | 930.44 |
Long-Term Leases | - | - | - | - | 1.34 | - |
Long-Term Unearned Revenue | 3.49 | 4.36 | 5.56 | 6.83 | 15.16 | 10.88 |
Long-Term Deferred Tax Liabilities | 3.78 | 3.86 | 3.61 | 3.55 | 5.94 | 3.17 |
Other Long-Term Liabilities | 6.04 | 4.93 | 38.04 | 89.83 | 79.65 | 59.91 |
Total Liabilities | 92.77 | 429.59 | 848.5 | 1,223 | 1,178 | 1,296 |
Common Stock | 745.67 | 728.59 | 609.17 | 536.69 | 536.62 | 536.56 |
Additional Paid-In Capital | 2,005 | 1,907 | 1,594 | 1,310 | 1,309 | 1,308 |
Retained Earnings | -1,630 | -1,727 | -1,761 | -1,749 | -1,616 | -1,388 |
Comprehensive Income & Other | - | 63.35 | 138.8 | 203.57 | 203.8 | 204.01 |
Total Common Equity | 1,121 | 972.18 | 580.87 | 301.27 | 432.96 | 660.41 |
Shareholders' Equity | 1,121 | 972.18 | 580.87 | 301.27 | 432.96 | 660.41 |
Total Liabilities & Equity | 1,214 | 1,402 | 1,429 | 1,524 | 1,611 | 1,956 |
Total Debt | - | 331.75 | 689.54 | 951.78 | 974.43 | 930.44 |
Net Cash (Debt) | 617.89 | 412.1 | 30.94 | -194.16 | -153.31 | -27.5 |
Net Cash Growth | 648.88% | 1232.00% | - | - | - | - |
Net Cash Per Share | 0.80 | 0.60 | 0.05 | -0.37 | -0.29 | -0.05 |
Filing Date Shares Outstanding | 745.67 | 728.59 | 609.17 | 536.69 | 536.62 | 536.56 |
Total Common Shares Outstanding | 745.67 | 728.59 | 609.17 | 536.69 | 536.62 | 536.56 |
Working Capital | 736.53 | 538.72 | 793.38 | 782.46 | 781.7 | 983.32 |
Book Value Per Share | 1.50 | 1.25 | 0.72 | 0.18 | 0.81 | 1.23 |
Tangible Book Value | 1,078 | 917.99 | 521.67 | 244.04 | 381.39 | 610.46 |
Tangible Book Value Per Share | 1.45 | 1.17 | 0.63 | 0.07 | 0.71 | 1.14 |
Buildings | - | 429.39 | 427.32 | 413.92 | 426.8 | 380.62 |
Machinery | - | 224.35 | 221.97 | 220.86 | 221.01 | 239.6 |
Construction In Progress | - | 0.03 | 0.03 | - | 0.9 | 44.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.